Lilly gets Fast Track designation for its experimental obesity drug
admin Eli Lilly and Co. LLY, +0.49% said Thursday that its experimental obesity drug received a…
Read Moreexperimental
Eisai shares indicated sharply higher after trial of experimental drug slows Alzheimer’s progression
Eisai Co. shares were indicated sharply higher Wednesday morning after the Japanese drug maker and…
Read MoreSpero’s stock jumps 188% after GSK licenses experimental antibiotic
Shares of Spero Therapeutics Inc. SPRO, +204.20% soared 188.4% in trading on Thursday morning after…
Read More